Skip to main content
Funded Studies

Berkley A. Lynch, PhD

Senior Director of CNS Research at Rodin Therapeutics

Location: Cambridge, MA United States

Dr. Berkley A. Lynch has worked in neuroscience drug discovery for more than 15 years, focusing most recently on diseases of neurodegeneration. He holds a PhD in biochemistry from The Rockefeller University in New York and has expertise in the full range of pre-clinical drug development activities, including biochemistry, cell and molecular biology, and in vitro and in vivo pharmacology. In his career, he has worked at ARIAD Pharmaceuticals, UCB Inc., Link Medicine and Dotmatics Inc. He has consulted for multiple biotechnology companies and now serves as senior director of CNS research at Rodin Therapeutics. Dr. Lynch has lead research identifying targets and developing assays around Parkinson’s and other neurodegenerative diseases and epilepsy, and has supervised testing of possible therapeutics in models of Parkinson’s and other diseases.

Associated Grants

  • Effect of HDAC Inhibition in Models of Parkinson's Disease


  • Pharmacodynamic Biomarkers of Drug-induced Protein Clearance in Rodent Cerebrospinal Fluid


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.